Longitude Capital Partners III LLC 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-30 5:16 pm Sale |
2023-10-19 | 13D | Talaris Therapeutics, Inc. TALS |
Longitude Capital Partners III LLC | 322,077 1.600% |
-1 (-0.00%) |
Filing |
| 2021-05-21 4:28 pm Purchase |
2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS |
Longitude Capital Partners III LLC | 322,078 7.800% |
322,078 (New Position) |
Filing |